Beryl Capital Management LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-23 4:22 pm Purchase |
2025-05-16 | 13G | Inozyme Pharma, Inc. INZY |
Beryl Capital Management LLC | 6,321,584 9.800% |
6,321,584 (New Position) |
Filing |